Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued)
Title:Editorial (Thematic Issue: Nutrition and Immunology in Diabetes, Cancer and Infectious Diseases)
Volume: 14 Issue: 1
Author(s): Dra. C. Rebeca Monroy Torres
Affiliation:
Export Options
About this article
Cite this article as:
Monroy Torres C. Rebeca Dra., Editorial (Thematic Issue: Nutrition and Immunology in Diabetes, Cancer and Infectious Diseases), Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) 2014; 14 (1) . https://dx.doi.org/10.2174/187152221401140812144142
DOI https://dx.doi.org/10.2174/187152221401140812144142 |
Print ISSN 1871-5222 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6115 |
22
Related Articles
-
FoxO1 Inhibitors: The Future Medicine for Metabolic Disorders?
Current Diabetes Reviews Therapeutic Potential of High Mobility Group Box-1 in Ischemic Injury and Tissue Regeneration
Current Vascular Pharmacology Genistein: A Phytoestrogen with Multifaceted Therapeutic Properties
Mini-Reviews in Medicinal Chemistry Antioxidant Therapy for Prevention of Inflammation, Ischemic Reperfusion Injuries and Allograft Rejection
Cardiovascular & Hematological Agents in Medicinal Chemistry Neurotrophin-3 Stimulates Migration of Mesenchymal Stem Cells Overexpressing TrkC
Current Medicinal Chemistry The Injured Cochlea as a Target for Inflammatory Processes, Initiation of Cell Death Pathways and Application of Related Otoprotective Strategies
Recent Patents on CNS Drug Discovery (Discontinued) The Challenges of Modeling Drug Resistance to Antiangiogenic Therapy
Current Drug Targets Heat Shock Protein 90 Inhibitors in Oncology
Current Proteomics Stem Cell Therapies
Recent Patents on Regenerative Medicine The Roles of MicroRNAs in Atherosclerosis
Current Medicinal Chemistry Management of Gene Variants of Unknown Significance: Analysis Method and Risk Assessment of the VHL Mutation p.P81S (c.241C>T)
Current Genomics Micro- and Nano-particulate Strategies for Antigen Specific Immune Tolerance to Treat Autoimmune Diseases
Pharmaceutical Nanotechnology Current View from Alzheimer Disease to Type 2 Diabetes Mellitus
CNS & Neurological Disorders - Drug Targets The Role of ABC Transporters in Drug Resistance, Metabolism and Toxicity
Current Drug Delivery Immune Checkpoint Inhibitors and Cardiac Toxicity: An Emerging Issue
Current Medicinal Chemistry Patent Selections
Recent Patents on DNA & Gene Sequences Genomic Sequencing of Key Genes in Mouse Pancreatic Cancer Cells
Current Molecular Medicine Cell Cycle Kinases in Osteosarcoma: Potential for Therapeutic Intervention
Current Pharmaceutical Design The Life Cycle of Cutaneous T Cell Lymphoma Reveals Opportunities for Targeted Drug Therapy
Current Cancer Drug Targets Heme Oxygenase-1 as a Target for the Design of Gene and Pharmaceutical Therapies for Autoimmune Diseases
Current Gene Therapy